Back to top

genomics: Archive

Ekta Bagri

3 Promising Genomics Stocks to Keep an Eye On in 2025

Investors interested in the Genomics and Synthetic Biology theme should keep an eye on MGTX, BEAM and KRYS.

BEAMNegative Net Change NTLANegative Net Change KRYSNegative Net Change MGTXPositive Net Change

Sundeep Ganoria

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

REGNNegative Net Change VRTXNegative Net Change NTLANegative Net Change CRSPNegative Net Change